Abstract
Morningstar, Inc. will publish quarterly results on April 29, 2026 Post Market; investors are looking for mid–single-digit revenue growth, expanding profitability, and confirmation that recent product moves and portfolio changes are translating into higher earnings quality.Market Forecast
Based on the latest projections, Morningstar, Inc. is expected to deliver revenue of 626.91 million US dollars this quarter, representing 7.01% year-over-year growth; EPS is estimated at 2.66, implying 29.13% year-over-year growth, with EBIT projected at 153.43 million US dollars, up 13.61% year over year. There is no formal forecast for gross profit margin or net profit margin in the compiled estimates, but the prior quarter’s profitability profile sets a high bar for operating leverage if revenue tracks the mid–single-digit outlook.The near-term commercial focus centers on deepening adoption of its research, data, index and analytics offerings; product updates and platform integration initiatives are positioned to support stable client retention and cross-sell momentum. Within the portfolio, licensing-driven businesses stand out as the most promising engine: licensing fees contributed 1.72 billion US dollars in the latest revenue mix view, and the company’s recent 8.10% organic growth in the prior quarter offers a reasonable baseline for directional expectations.
Last Quarter Review
Morningstar, Inc. reported last quarter revenue of 641.10 million US dollars, up 8.48% year over year, with a gross profit margin of 61.13%; GAAP net income attributable to the company was 115.00 million US dollars, translating to a 17.95% net profit margin, and adjusted EPS was 2.71, up 26.64% year over year. A key highlight was the expansion in profitability, as adjusted operating performance accelerated and net income improved sequentially, with net profit up 25.66% quarter on quarter on the back of solid top-line growth and cost discipline. From a business-mix standpoint, licensing fees represented 70.30% of the revenue structure at 1.72 billion US dollars, while transaction services and asset management services contributed 383.30 million US dollars and 343.00 million US dollars respectively during the reference period, against a backdrop of 8.48% companywide year-over-year growth.Current Quarter Outlook
Core revenue engines: Research, data, and index licensing
The revenue consensus for the current quarter at 626.91 million US dollars, up 7.01% year over year, implies a modest pullback from the immediately preceding quarter’s level but maintains the multi-quarter trajectory of mid–single-digit to high–single-digit growth. The product pillars most central to this outcome are research subscriptions, data platforms, and index licensing—areas where client stickiness tends to be high and where incremental enhancements can drive upsell and renewal rates. Recent quarters showed gross margins above 60%, and if revenue lands near expectations, fixed-cost absorption and disciplined expense control can support solid operating leverage into EPS, which is forecast to rise 29.13% year over year to 2.66.Strategically, the company has continued to modernize its workflows and client-facing capabilities. Management embedded an AI assistant into its advisor-facing suite to streamline research discovery, meeting preparation, and statement analytics; while revenue attribution will diffuse across multiple subscription lines, such features can improve product utility and time-to-value for customers, strengthening renewal dynamics over time. Portfolio activity also matters: completed acquisition of the Center for Research in Security Prices (CRSP) broadens the high-quality data catalog underpinning licensing and analytics, while planned divestiture of the ByAllAccounts aggregation unit simplifies the footprint and focuses capital on higher-return areas. These actions are likely to sustain the licensing-led mix that underpins the current-quarter revenue forecast and support stable gross margins through product differentiation.
From a quarter-on-quarter perspective, the seasonality and billing cadence can create variability in reported top-line levels even when annualized demand is healthy. With the estimate pointing to 626.91 million US dollars, investors will watch for subscription and licensing renewal rates, new product attach rates, and net price realization to confirm that mid–single-digit reported revenue growth aligns with high–single-digit organic trends seen previously. Any commentary on client budgets and purchasing cycles should help frame the revenue run-rate for upcoming quarters and clarify whether the current-quarter profile is a conservative reset or a sustainable pace.
High-potential growth vector: Index solutions and private markets data
Within the broader portfolio, index licensing and private markets data continue to offer attractive scaling characteristics. The licensing-led category contributed 1.72 billion US dollars in the latest revenue mix view and commands strong operating economics due to data reusability and multiyear agreements. Recent index innovation, such as the launch of targeted thematic and private-markets–oriented benchmarks, aims to broaden use cases for asset managers and wealth platforms. The CRSP acquisition complements this strategy by adding widely respected historical and index data, which can be embedded across analytics workflows and packaged for institutional licensing, enhancing the addressable customer set for data-driven products.Private markets data and analytics anchor longer-term growth as investors seek transparency across both public and private assets. The company’s initiatives to unify public and private data, including new indexing options and enhanced analytics, position the portfolio to capture incremental spend as asset owners, managers, and advisors require more holistic tools. While the near-term revenue estimate implies 7.01% year-over-year growth at the consolidated level, execution in index partnerships and private-markets content delivery can skew mix toward higher-margin licensing revenue, supporting the projected 13.61% year-over-year EBIT growth to 153.43 million US dollars. If client adoption rates meet expectations, the uplift to profitability could outpace revenue growth, reinforcing the EPS estimate of 2.66 despite ongoing investment in product and platform capabilities.
For this quarter specifically, investors will look for evidence that the index pipeline is converting into licensing wins and that private markets data continues to add new customers or deeper seat penetration. Additionally, cross-sell across research, data, and analytics platforms can maintain momentum where new product launches—such as advisor tools augmented with AI—make discovery and evaluation faster. Successful conversion and retention in these categories would validate the case for sustained high–single-digit organic growth potential over the medium term.
Stock-price swing factors this quarter
Three variables are poised to dominate the share-price reaction: organic revenue growth, incremental margins, and portfolio focus. First, organic revenue growth will likely set the tone; an outcome close to or above the prior quarter’s 8.10% organic pace would be a clear positive signal, while a print materially below the 7.01% year-over-year estimate could raise questions on demand timing or client budgets. Second, incremental margins and expense discipline will be scrutinized; with last quarter’s gross profit margin at 61.13% and net profit margin at 17.95%, modest top-line growth should translate efficiently to EBIT and EPS if fixed costs remain contained and mix favors licensing and data. Third, portfolio focus and capital deployment will be evaluated; closing conditions and integration updates around the CRSP acquisition, progress on divesting ByAllAccounts within the first half, and the continuation of a 0.50 US dollars quarterly dividend can collectively shape investor perception of earnings quality and cash return priorities.Management commentary around product adoption will be especially consequential for valuation. Updates on the AI-enabled advisor suite rollout in the United States and planned availability in Canada through 2026 will help investors gauge the pace of ARR expansion and multi-product penetration within advisor and enterprise accounts. Similarly, clarity on index partner pipelines and the monetization of private-markets capabilities can inform how much of the growth is mix-accretive. If these levers line up, the pathway to the forecasted EPS of 2.66 with 29.13% year-over-year growth becomes more visible, setting expectations for continued improvement in full-year profitability.
Finally, revenue composition remains a nuance to monitor. Transaction-related lines can fluctuate with market activity, while asset-related fees may reflect market levels and flows. Licensing and subscription anchors are more stable, so commentary on renewal rates, net retention, pricing, and customer wins will help investors discern whether the consolidated 626.91 million US dollars projection is conservative or well-calibrated. Taken together, the balance of evidence points to a quarter defined by execution on licensing-led growth, product adoption headlines, and disciplined cost management.
Analyst Opinions
The balance of published opinions in the quarter-to-date window is decisively bullish, with a 100% bullish-to-bearish ratio among identifiable institutional commentaries. UBS maintained a Buy rating while adjusting its price target to 280 US dollars, citing a supportive outlook for margin expansion and monetization from core data and index assets in the coming quarters. Separately, BMO Capital reiterated a Buy rating with a 193 US dollars price target, emphasizing the durability of the company’s data moat and the potential for operating margin improvement as product investments scale.The analytical consensus coalesces around three themes that align with the quarter’s setup. First, near-term revenue expectations at 626.91 million US dollars, up 7.01% year over year, are seen as attainable within the prevailing demand environment for research and datasets, where renewal rates and pricing typically provide a baseline even as new product attach supports incremental growth. Second, profitability is expected to inflect positively, with forecasts calling for EBIT of 153.43 million US dollars and EPS of 2.66, up 13.61% and 29.13% year over year respectively; analysts attribute this to a combination of modestly stronger revenue and a favorable mix shift toward licensing-heavy categories. Third, recent portfolio moves—completing the CRSP purchase and pursuing divestiture of ByAllAccounts—are viewed as accretive to strategic focus, with the former bolstering index and historical data breadth and the latter streamlining lower-synergy components.
From a stock-reaction standpoint, bullish research notes underscore that the path to upside rests on confirming organic growth resilience and demonstrating incremental margin capture in the quarter. Analysts expect management to provide qualitative evidence of traction for the advisor AI assistant and updates on index licensing momentum; these signals would support a view that product enhancements can compound subscription and licensing revenue through better engagement and broader utility. Moreover, the dividend maintenance at 0.50 US dollars per share for the April 30, 2026 payment date reflects a balance of reinvestment and shareholder returns that, according to supportive views, should reinforce confidence in cash generation.
In summary, the majority outlook is constructive: the projected 7.01% revenue growth and 29.13% EPS expansion imply operating leverage that appears achievable if licensing-led mix and disciplined spending persist. Analysts aligned with this stance see room for estimate stability or upward revisions should the company deliver evidence of sustained renewal strength, healthy attach rates for new features, and clear progress integrating newly acquired data assets into commercial workflows across research, index, and analytics offerings.
Comments